atai Life Sciences (ATAI) Misses Q2 EPS by 1c

atai Life Sciences (NASDAQ: ATAI) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $170 thousand, versus $0 reported last year.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MP Materials seen largely insulated after China export-control move